The US Food and Drug Administration combined its estimates on separate parts of dietary supplement firms' regulatory burden from good manufacturing practices requirements in 2020, though the Natural Products Association ays the agency continues underestimating the costs.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?